1q3d

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1q3d" size="450" color="white" frame="true" align="right" spinBox="true" caption="1q3d, resolution 2.20&Aring;" /> '''GSK-3 Beta complexe...)
Line 1: Line 1:
-
[[Image:1q3d.gif|left|200px]]<br />
+
[[Image:1q3d.gif|left|200px]]<br /><applet load="1q3d" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1q3d" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1q3d, resolution 2.20&Aring;" />
caption="1q3d, resolution 2.20&Aring;" />
'''GSK-3 Beta complexed with Staurosporine'''<br />
'''GSK-3 Beta complexed with Staurosporine'''<br />
==Overview==
==Overview==
-
GSK-3beta is a regulatory serine/threonine kinase with a plethora of, cellular targets. Consequently, selective small molecule inhibitors of, GSK-3beta may have a variety of therapeutic uses including the treatment, of neurodegenerative diseases, type II diabetes and cancer. In order to, characterize the active site of GSK-3beta, we determined crystal, structures of unphosphorylated GSK-3beta in complex with selective and, non-selective ATP-mimetic inhibitors. Analysis of the inhibitors', interactions with GSK-3beta in the structures reveals how the enzyme can, accommodate a number of diverse molecular scaffolds. In addition, a, conserved water molecule near Thr138 is identified that can serve a, functional role in inhibitor binding. Finally, a comparison of the, interactions made by selective and non-selective inhibitors highlights, residues on the edge of the ATP binding-site that can be used to obtain, inhibitor selectivity. Information gained from these structures provides a, promising route for the design of second-generation GSK-3beta inhibitors.
+
GSK-3beta is a regulatory serine/threonine kinase with a plethora of cellular targets. Consequently, selective small molecule inhibitors of GSK-3beta may have a variety of therapeutic uses including the treatment of neurodegenerative diseases, type II diabetes and cancer. In order to characterize the active site of GSK-3beta, we determined crystal structures of unphosphorylated GSK-3beta in complex with selective and non-selective ATP-mimetic inhibitors. Analysis of the inhibitors' interactions with GSK-3beta in the structures reveals how the enzyme can accommodate a number of diverse molecular scaffolds. In addition, a conserved water molecule near Thr138 is identified that can serve a functional role in inhibitor binding. Finally, a comparison of the interactions made by selective and non-selective inhibitors highlights residues on the edge of the ATP binding-site that can be used to obtain inhibitor selectivity. Information gained from these structures provides a promising route for the design of second-generation GSK-3beta inhibitors.
==About this Structure==
==About this Structure==
-
1Q3D is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with STU as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1Q3D OCA].
+
1Q3D is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=STU:'>STU</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Q3D OCA].
==Reference==
==Reference==
Line 15: Line 14:
[[Category: Non-specific serine/threonine protein kinase]]
[[Category: Non-specific serine/threonine protein kinase]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Bertrand, J.A.]]
+
[[Category: Bertrand, J A.]]
[[Category: Cristiani, C.]]
[[Category: Cristiani, C.]]
[[Category: Flocco, M.]]
[[Category: Flocco, M.]]
-
[[Category: Kalisz, H.M.]]
+
[[Category: Kalisz, H M.]]
[[Category: Knapp, S.]]
[[Category: Knapp, S.]]
[[Category: Thieffine, S.]]
[[Category: Thieffine, S.]]
Line 27: Line 26:
[[Category: kinase]]
[[Category: kinase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:50:03 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:35:24 2008''

Revision as of 12:35, 21 February 2008


1q3d, resolution 2.20Å

Drag the structure with the mouse to rotate

GSK-3 Beta complexed with Staurosporine

Overview

GSK-3beta is a regulatory serine/threonine kinase with a plethora of cellular targets. Consequently, selective small molecule inhibitors of GSK-3beta may have a variety of therapeutic uses including the treatment of neurodegenerative diseases, type II diabetes and cancer. In order to characterize the active site of GSK-3beta, we determined crystal structures of unphosphorylated GSK-3beta in complex with selective and non-selective ATP-mimetic inhibitors. Analysis of the inhibitors' interactions with GSK-3beta in the structures reveals how the enzyme can accommodate a number of diverse molecular scaffolds. In addition, a conserved water molecule near Thr138 is identified that can serve a functional role in inhibitor binding. Finally, a comparison of the interactions made by selective and non-selective inhibitors highlights residues on the edge of the ATP binding-site that can be used to obtain inhibitor selectivity. Information gained from these structures provides a promising route for the design of second-generation GSK-3beta inhibitors.

About this Structure

1Q3D is a Single protein structure of sequence from Homo sapiens with as ligand. Active as Non-specific serine/threonine protein kinase, with EC number 2.7.11.1 Full crystallographic information is available from OCA.

Reference

Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors., Bertrand JA, Thieffine S, Vulpetti A, Cristiani C, Valsasina B, Knapp S, Kalisz HM, Flocco M, J Mol Biol. 2003 Oct 17;333(2):393-407. PMID:14529625

Page seeded by OCA on Thu Feb 21 14:35:24 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools